GenoFocus Inc (187420) — Cash Flow Reinvestment Rate

Latest as of December 2025: 7.15x

GenoFocus Inc (187420) has a Cash Flow Reinvestment Rate of 7.15x as of December 2025, reinvesting ₩2.06 Billion (capex ₩138.88 Million plus investments ₩-1.92 Billion) from operating cash flow of ₩288.09 Million. Explore 187420 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

7.15x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.06 Billion
Capex + Investments

Operating Cash Flow

₩288.09 Million
KRW

Capital Expenditures

₩138.88 Million
KRW

GenoFocus Inc Cash Flow Reinvestment Rate (2015–2025)

Historical reinvestment intensity for GenoFocus Inc across 6 annual periods. Also explore GenoFocus Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for GenoFocus Inc (2015–2025)

Year-by-year capital reinvestment analysis for GenoFocus Inc. For live market cap and broader valuation context, see how much is GenoFocus Inc worth.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 2.28x ₩8.00 Billion ₩3.50 Billion ₩1.08 Billion ▼ -8.4%
2024 2.49x ₩7.15 Billion ₩2.87 Billion ₩699.16 Million ▼ -75.3%
2018 10.10x ₩15.80 Billion ₩1.56 Billion ₩7.42 Billion ▼ -4.5%
2017 10.58x ₩14.43 Billion ₩1.36 Billion ₩2.06 Billion ▼ -85.6%
2016 73.60x ₩37.98 Billion ₩516.09 Million ₩5.46 Billion ▲ +2249.8%
2015 3.13x ₩8.94 Billion ₩2.85 Billion ₩8.14 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow